Stahl Law Firm v. Apex Medical Technologies CA4/1

CourtCalifornia Court of Appeal
DecidedAugust 26, 2020
DocketD072906
StatusUnpublished

This text of Stahl Law Firm v. Apex Medical Technologies CA4/1 (Stahl Law Firm v. Apex Medical Technologies CA4/1) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Stahl Law Firm v. Apex Medical Technologies CA4/1, (Cal. Ct. App. 2020).

Opinion

Filed 8/26/20 Stahl Law Firm v. Apex Medical Technologies CA4/1 NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

COURT OF APPEAL, FOURTH APPELLATE DISTRICT

DIVISION ONE

STATE OF CALIFORNIA

STAHL LAW FIRM et al, D072906

Plaintiffs, Cross-defendants and Appellants, (Super. Ct. No. 37-2010- 00097839-CU-CP-CTL) v.

APEX MEDICAL TECHNOLOGIES, INC., et al.,

Defendants, Cross-complainants and Appellants.

APPEALS from a judgment of the Superior Court of San Diego County,

Katherine Bacal, Judge. Affirmed as modified.

Norbert Stahl, in pro. per., for Plaintiffs, Cross-defendants and

Appellants.

Arthur A. Wellman, Jr. for Defendants, Cross-complainants and

Appellants. This appeal arises from a dispute over legal fees and the quality of the

legal services for which those fees were charged. In 2007 and 2008, I-Flow

Corporation (I-Flow) filed lawsuits against Apex Medical Technologies, Inc.

(Apex) and Zone Medical LLC (Zone) alleging patent infringement and trade

secret misappropriation. Norbert Stahl, the sole attorney for Stahl Law

Firm, represented Apex and Zone in the litigation. I-Flow prevailed at trial

and, thereafter, the parties negotiated a settlement of the dispute.

Thereafter, Stahl filed a complaint against Apex, Zone, and a number

of company officers, including Mark McGlothlin, Alice DePaul, and Michael

Marasco (collectively, the Zone Defendants) seeking recovery for unpaid legal

fees related to the I-Flow litigation. The Zone defendants responded with a

cross-complaint alleging professional malpractice and breach of fiduciary

duty. After the Zone Defendants presented their affirmative evidence on the

cross-complaint, the superior court granted a motion for nonsuit on the

professional malpractice cause of action. At the conclusion of the case, the

jury found in favor of the Zone defendants on all remaining causes of action

and awarded damages to Zone, Apex, and McGlothlin pursuant to their claim

for breach of fiduciary duty.

Stahl appeals from the judgment and asserts the damages awarded to

Zone, Apex, and McGlothlin must be vacated as a matter of law in light of the

allegations in the cross-complaint, the superior court’s grant of nonsuit, and

2 inconsistencies in the special verdict form submitted by the jury. The Zone

Defendants cross-appeal and argue the superior court erred by granting

Stahl’s motion for nonsuit on the professional malpractice cause of action. In

a separately-filed motion, the Zone Defendants ask this court to dismiss

Stahl’s appeal based on the disentitlement doctrine.

We decline to exercise our discretion under the disentitlement doctrine

to dismiss Stahl’s appeal. We conclude the superior court did not err by

granting the motion for nonsuit and that the damages awarded to Apex and

Zone were appropriate but that the damages awarded to McGlothlin must be

vacated.

FACTUAL AND PROCEDURAL BACKGROUND

Underlying Litigation (The Patent Litigation)

McGlothlin and DePaul founded Apex in 1985 and founded Zone in or

around 2007. Apex manufactured an elastomeric infusion pump called the

Solace pump and Zone distributed the pump. I-Flow also manufactured and

sold elastomeric infusion pumps, and the pumps sold by Apex competed with

I-Flow’s pumps for market share.

In late 2006, I-Flow sent a letter to McGlothlin, as president of Apex. I-

Flow alleged that the Solace pump infringed United States Patent No.

5,284,481 (the ‘481 Patent), which had been assigned to I-Flow, and

demanded that Apex immediately stop making, using, or selling the Solace

3 pump. Apex sent the letter to a patent attorney, Henry Heines. Heines

conducted an analysis of the ‘481 patent and determined the Solace pump did

not infringe any claims of the patent. He sent a letter to I-Flow’s attorneys

containing his analysis.

On June 29, 2007, I-Flow filed a complaint in the federal district court

for patent infringement against Apex. Just a few days later, on July 3, Stahl

sent an unsolicited letter to McGlothlin, as president of Apex, noting the

complaint filed by I-Flow and offering to represent Apex. In the letter, Stahl

stated that he was “a patent attorney with over 10 years of experience in

helping inventors and companies in patent matters in Courts and in the

Patent Office.”

In August, Heines provided Apex with a detailed non-infringement

opinion, in which he concluded that neither the Solace pump nor any of the

commercial activities associated with it infringed the ‘481 Patent.1

In September, McGlothlin engaged Stahl to represent Apex and Zone in

patent prosecution related to catheter technology and the Patent Litigation.

The engagement letter indicated Stahl would charge an hourly rate of $280

for his services, with a $20 per hour discount for litigation services.

1 It is common practice for a company or individual threatened with patent litigation to obtain such a written opinion of counsel as a basis to avoid treble damages based on the willful infringement of the patent. (See Halo Electronics, Inc. v. Pulse Electronics, Inc. (2016) 136 S.Ct. 1923, 1935.) 4 Thereafter, I-Flow named McGlothlin as a defendant in the federal

lawsuit against Apex and filed a second complaint against Zone. The cases

were consolidated and I-Flow amended its complaint to add claims for trade

secret misappropriation, breach of confidence, and unfair competition.

Specifically, I-Flow alleged that Apex obtained and disclosed I-Flow trade

secrets. I-Flow also alleged that McGlothlin personally obtained and

disclosed confidential business information.

At the conclusion of the trial, in October 2009, the jury found that the

‘481 Patent was valid and that Apex willfully infringed claims 1, 2, and 15.

The jury awarded I-Flow nearly $3 million on the patent claims. The jury

also found that Apex and McGlothlin willfully and maliciously

misappropriated at least one of I-Flow’s trade secrets, breached I-Flow’s

confidence, and engaged in unfair competition against I-Flow. The jury

awarded approximately $9 million in damages to I-Flow on those claims, with

the liability split between Apex and McGlothlin.

Litigation Between Stahl and the Zone Defendants (The Malpractice/Fee Litigation) The following February, Stahl filed a complaint against the Zone

Defendants seeking approximately $100,000 in unpaid legal fees. The

complaint listed the following five causes of action: 1) breach of contract; 2)

breach of covenant of good faith and fair dealing; 3) quantum meruit for

services rendered; 4) open book account; and 5) account stated. 5 The Zone Defendants asserted numerous affirmative defenses and also

filed a cross-complaint alleging causes of action for professional malpractice

and breach of fiduciary duty. In the professional malpractice cause of action,

they alleged that Stahl failed to conduct proper investigation and discovery;

failed to retain, designate, and prepare appropriate expert witnesses; failed

to submit complete expert reports; failed to designate relevant witnesses,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Biomedino, LLC v. Waters Technologies Corporation
490 F.3d 946 (Federal Circuit, 2007)
Sargon Enterprises, Inc. v. University of Southern California
288 P.3d 1237 (California Supreme Court, 2012)
Vons Companies, Inc. v. Seabest Foods, Inc.
926 P.2d 1085 (California Supreme Court, 1996)
Tobin v. Casaus
275 P.2d 792 (California Court of Appeal, 1954)
In Re Fountain
74 Cal. App. 3d 715 (California Court of Appeal, 1977)
Glendale Federal Savings & Loan Ass'n v. Marina View Heights Development Co.
66 Cal. App. 3d 101 (California Court of Appeal, 1977)
Tan Jay International, Ltd. v. Canadian Indemnity Co.
198 Cal. App. 3d 695 (California Court of Appeal, 1988)
Stone v. Bach
80 Cal. App. 3d 442 (California Court of Appeal, 1978)
Truestone, Inc. v. Travelers Insurance
55 Cal. App. 3d 165 (California Court of Appeal, 1976)
New Tek Manufacturing, Inc. v. Beehner
702 N.W.2d 336 (Nebraska Supreme Court, 2005)
San Diego County Water Authority v. Metropolitan Water District
11 Cal. Rptr. 3d 446 (California Court of Appeal, 2004)
Jamison v. Jamison
164 Cal. App. 4th 714 (California Court of Appeal, 2008)
City of Ripon v. Sweetin
122 Cal. Rptr. 2d 802 (California Court of Appeal, 2002)
Stanley v. Richmond
35 Cal. App. 4th 1070 (California Court of Appeal, 1995)
Bird, Marella, Boxer & Wolpert v. Superior Court
130 Cal. Rptr. 2d 782 (California Court of Appeal, 2003)
Hanson v. Superior Court
109 Cal. Rptr. 2d 782 (California Court of Appeal, 2001)
ORRICK HERRINGTON & SUTCLIFFE LLP v. Superior Court
132 Cal. Rptr. 2d 658 (California Court of Appeal, 2003)
Mattco Forge, Inc. v. Arthur Young & Co.
52 Cal. App. 4th 820 (California Court of Appeal, 1997)
Fundamental Investment Growth Shelter Realty Fund v. Gradow
28 Cal. App. 4th 966 (California Court of Appeal, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Stahl Law Firm v. Apex Medical Technologies CA4/1, Counsel Stack Legal Research, https://law.counselstack.com/opinion/stahl-law-firm-v-apex-medical-technologies-ca41-calctapp-2020.